Session date: 
Tuesday, April 23, 2019 - 3:30pm to 4:30pm
Location: 
Hub for Collaborative Medicine
8701 Watertown Plank
Hub Room A7520/7628
Milwaukee, WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Program Description: 

The Medical College of Wisconsin (MCW) has a mission to be the national leader in providing high quality healthcare. One of the ways that we are doing this is to provide high quality continuing medical education (CME) to our faculty; this includes presentation from national leaders in the field of Nephrology. Our education al topics focus on outcomes research in chronic kidney disease and end-stage renal disease, delivery of care in dialysis units and chronic kidney disease clinics, emerging data on new treatments compared to current standard of care, continuing review of kidney biopsy pathology, and basic science research that may become future therapeutics.

Target audience: 
  • Physicians
  • Physicians Assistants
  • Nurse/Nurse Practitioners
  • Medical Students
Learning objectives: 

At the end of this session, I will be able to:

  1. Describe the pharmacology of SGLT2 inhibitors.
  2. Understand the design and results of the Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy Study.
  3. Determine the most appropriate candidates for Canagliflozin treatment to prevent progression of diabetic nephropathy.
Faculty & credentials: 
Planning Team Members:
Dawn Wolfgram, MD
Kevin Regner, MD

 

 

Presenter(s):
Kevin Regner, MD, MS, FASN
Professor of Medicine
Chief of Nephrology
Department of Medicine
Medical College of Wisconsin
 
 

All persons in control of content have NO relevant financial relationships to disclose with the exception of the following person(s):


In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships.  These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

CME Coordinator Contact Information

Name: 
Carriann Horstead
Phone number: 
+1 (414) 955-0300